“Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting MTOR and NGFR Pathways”. 2026. Science Essence Journal 42 (1): 50-70. https://doi.org/10.69523/sej.2026.42.17130.